Evercore ISI Group Initiates Coverage On Kailera Therapeutics with Outperform Rating

Benzinga Newsdesk www.benzinga.com Positive 86.7%

Neg 0% Neu 0% Pos 86.7%

Evercore ISI Group analyst Umer Raffat initiates coverage on Kailera Therapeutics (NASDAQ:KLRA) with a Outperform rating.